Triangle Park (Quezon City)

Turnbridge Equities Acquires 74-acre Site in Raleigh, North Carolina, for 302-Unit Single-Family Build-to-Rent Development

Retrieved on:

星期四, 五月 30, 2024

Construction & Property, Residential Building & Real Estate, Restaurant, Stock, Raleigh–Durham International Airport, Investment, Triangle, Research Triangle, Growth, Mutual Tower, Acquisition, Completeness, Research, I-87, Creamery, Triangle Park (Quezon City), Project

Turnbridge Equities (“Turnbridge”), a vertically-integrated real estate investment and development firm, has announced the acquisition of approximately 74 acres on Mailman Road in Knightdale, North Carolina.

Key Points:

Turnbridge Equities (“Turnbridge”), a vertically-integrated real estate investment and development firm, has announced the acquisition of approximately 74 acres on Mailman Road in Knightdale, North Carolina.
Situated 15 minutes from downtown Raleigh, the 73.9-acre site will be developed as Mailman Post, a 302-unit residential development (the “Project”).
Prior to acquiring the property, Turnbridge obtained entitlements, including zoning, site plan, annexation, and utility allocation, for a mix of 302 townhouses and single-family detached homes.
For more information about Turnbridge Equities and its portfolio, please visit www.turnbridgeequities.com .

Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

Retrieved on:

星期五, 五月 24, 2024

The new $5.3 billion expansion brings Lilly’s total LEAP investment to $9 billion and will enhance Lilly’s capacity to manufacture active pharmaceutical ingredients (API) for its latest type 2 diabetes and obesity medicines.

Key Points:

The new $5.3 billion expansion brings Lilly’s total LEAP investment to $9 billion and will enhance Lilly’s capacity to manufacture active pharmaceutical ingredients (API) for its latest type 2 diabetes and obesity medicines.
Lilly has long been driving global innovation and economic growth that will be felt for decades here at home,” said Gov.
In May 2022, Lilly first announced its plans to invest $2.1 billion and create up to 500 new jobs at LEAP.
At the company’s Lebanon groundbreaking in April 2023, Lilly announced an additional $1.6 billion investment and 200 new jobs at the site.

WAKE RADIOLOGY SUPPORTS TRIANGLE RACE FOR THE CURE WITH THIRD LARGEST TEAM, $11,100 CONTRIBUTION

Retrieved on:

星期二, 五月 7, 2024

Cancer, Cure, Mammography, Woman, Breast cancer, Radiology, Triangle Park (Quezon City), Research, Survivor, Disease, Patient, Triangle, Star Wars Day

RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, the oldest and largest outpatient imaging provider in the Triangle, contributed $11,100 to breast cancer research as a Gold Sponsor of the 2024 Komen Triangle Race for the Cure, held Saturday, May 4, at Boxyard RTP in Research Triangle Park.

Key Points:

RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare, the oldest and largest outpatient imaging provider in the Triangle, contributed $11,100 to breast cancer research as a Gold Sponsor of the 2024 Komen Triangle Race for the Cure, held Saturday, May 4, at Boxyard RTP in Research Triangle Park.
This year, more than 50 members of the Wake Radiology team participated in the 5K race, two of whom are breast cancer survivors.
As an added incentive to schedule an exam, Wake Radiology offered race participants and spectators a chance to enter to win four on-site giveaways.
For more information, or to make a gift in support of breast cancer research and patients, please visit https://www.komen.org/how-to-help/attend-events/race-for-the-cure/ .

Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park

Retrieved on:

星期一, 五月 6, 2024

Messenger, DNA, Research Triangle Park, Triangle Park (Quezon City), Research, Organization, AAV, CGT, NGS, Pharmaceutical industry

KAISERAUGST, Switzerland, May 6, 2024 /PRNewswire/ -- Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development.

Key Points:

KAISERAUGST, Switzerland, May 6, 2024 /PRNewswire/ -- Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development.
It will offer critical cell-based potency assays, advanced Next-Gen Sequencing (NGS) capabilities, and related testing services supporting multiple biologic modalities.
From the outset, the new testing center will support characterization and release testing of CGT and other advanced therapies, including Adeno-Associated virus (AAV) gene therapies, mRNA therapies and antibody drug conjugates.

Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park

Retrieved on:

星期一, 五月 6, 2024

Messenger, DNA, Research Triangle Park, Triangle Park (Quezon City), Research, Organization, AAV, CGT, NGS, Pharmaceutical industry

KAISERAUGST, Switzerland, May 6, 2024 /PRNewswire/ -- Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development.

Key Points:

KAISERAUGST, Switzerland, May 6, 2024 /PRNewswire/ -- Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development.
It will offer critical cell-based potency assays, advanced Next-Gen Sequencing (NGS) capabilities, and related testing services supporting multiple biologic modalities.
From the outset, the new testing center will support characterization and release testing of CGT and other advanced therapies, including Adeno-Associated virus (AAV) gene therapies, mRNA therapies and antibody drug conjugates.

Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina

Retrieved on:

星期一, 四月 29, 2024

Survival, Research Triangle Park, Triangle Park (Quezon City), RTP, Pancreatic cancer

This work will be conducted at the lab in Research Triangle Park under the leadership and direction of Dr. Lisa Ford.

Key Points:

This work will be conducted at the lab in Research Triangle Park under the leadership and direction of Dr. Lisa Ford.
Moving its lab and U.S. headquarters to Research Triangle Park supports the strategy Immunovia announced in July 2023 to streamline operations and reduce costs.
The new space in Research Triangle Park (RTP) will be significantly smaller and less expensive than the company's existing lab in Marlborough, Massachusetts.
The lower cost of labor in Research Triangle Park should enable the company to staff the new lab at a lower cost.

Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina

Retrieved on:

星期一, 四月 29, 2024

Survival, Research Triangle Park, Triangle Park (Quezon City), RTP, Pancreatic cancer

This work will be conducted at the lab in Research Triangle Park under the leadership and direction of Dr. Lisa Ford.

Key Points:

This work will be conducted at the lab in Research Triangle Park under the leadership and direction of Dr. Lisa Ford.
Moving its lab and U.S. headquarters to Research Triangle Park supports the strategy Immunovia announced in July 2023 to streamline operations and reduce costs.
The new space in Research Triangle Park (RTP) will be significantly smaller and less expensive than the company's existing lab in Marlborough, Massachusetts.
The lower cost of labor in Research Triangle Park should enable the company to staff the new lab at a lower cost.

Toll Brothers Announces New Modern Townhome Community Coming Soon to Durham, North Carolina

Retrieved on:

星期四, 四月 18, 2024

Interstate Highway System, Sale, Interstate 40, University, Toll Brothers, Collection, Triangle Park (Quezon City), American Tobacco Trail, Garden, Duke University, Brother

DURHAM, N.C., April 18, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest townhome community, Rollingdale by Toll Brothers , is coming soon to Durham, North Carolina.

Key Points:

DURHAM, N.C., April 18, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest townhome community, Rollingdale by Toll Brothers , is coming soon to Durham, North Carolina.
The Toll Brothers Sales Center and model home are currently under construction and the community will open for sale in late summer 2024. summer 2024.
Located just five minutes from The Streets at Southpoint shopping mall, Rollingdale by Toll Brothers will be an intimate community of 33 modern townhomes in a prime location.
“Toll Brothers is excited to bring the best in high-end modern living to the vibrant Durham area,” said Ted Pease, Division Present of Toll Brothers in Raleigh.

Highwoods Announces Recent Disposition Activity

Retrieved on:

星期四, 四月 4, 2024

GAAP, Research Triangle Park, HIW, Triangle Park (Quezon City), Sale, UNC Rex Healthcare, Bank

RALEIGH, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has sold in a series of transactions non-core properties in Raleigh for combined gross proceeds of $79.4 million.

Key Points:

RALEIGH, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has sold in a series of transactions non-core properties in Raleigh for combined gross proceeds of $79.4 million.
Gross proceeds from dispositions closed in the first quarter of 2024 totaled $16.9 million with the remainder closing early in the second quarter.
As part of the sale of one building, the Company provided $6.2 million in non-recourse first mortgage seller financing.
The note is scheduled to mature in February 2025, but can be prepaid without penalty at any time prior to maturity.

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023

Retrieved on:

星期四, 三月 21, 2024

“As we look at 2024, there's a sense of optimism as we aim to hit significant milestones in the coming quarters.

Key Points:

“As we look at 2024, there's a sense of optimism as we aim to hit significant milestones in the coming quarters.
During the fourth quarter of 2023, the Company initiated five new Senhance Surgical System placements, one in Germany, one in Romania, two in the CIS region and one in Japan at Nagoya University Hospital.
In 2023, surgeons performed over 3,550 procedures utilizing the Senhance System, representing a 13% increase over the previous year.
In addition to regulatory milestones, the Company has introduced four Senhance System programs dedicated to pediatric departments in the U.S. and internationally.